APA (7th ed.) Citation

AMS, H., NS, A., AB, A., HA, A. D., EM, E., NO, E., & D, A. (2026). Targeting Nrf2/HO-1, NF-κB, and Apoptotic Pathways: Mechanistic Evaluation of Phlorizin Nanoparticles in Diabetic Renal Injury. Clinical and experimental pharmacology & physiology, 53(5), e70129. https://doi.org/10.1111/1440-1681.70129

Chicago Style (17th ed.) Citation

AMS, Hegazy, Alqahtani NS, Al-Ghafari AB, Al Doghaither HA, Elmorsy EM, El-Shaer NO, and Abdelhady D. "Targeting Nrf2/HO-1, NF-κB, and Apoptotic Pathways: Mechanistic Evaluation of Phlorizin Nanoparticles in Diabetic Renal Injury." Clinical and Experimental Pharmacology & Physiology 53, no. 5 (2026): e70129. https://doi.org/10.1111/1440-1681.70129.

MLA (9th ed.) Citation

AMS, Hegazy, et al. "Targeting Nrf2/HO-1, NF-κB, and Apoptotic Pathways: Mechanistic Evaluation of Phlorizin Nanoparticles in Diabetic Renal Injury." Clinical and Experimental Pharmacology & Physiology, vol. 53, no. 5, 2026, p. e70129, https://doi.org/10.1111/1440-1681.70129.